- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Lisa Henderson
Articles
Acquisition and Investment Spur AVEO Oncology to New Heights
Ahead of ASCO and BIO, Michael Bailey CEO of AVEO Oncology, discusses the company becoming an LG Chem subsidiary and the future for drug development in the combined entity.
PCC 2023: ESG, New Turf for Compliance
While ESG is still in the early stages for pharma, many companies are moving forward with a need for compliance.
Pharma 2023: Marketing to the Masses
Digital and innovation leader takes issue with the current state of pharma marketing and suggests new approaches are needed.
Pharma 2023: Digital Health Key Takeaways
Industry insights on how pharma is faring in tapping new innovations and approaches in digital health.
Pharma 2023: Unleash RWE Benefits Along the Value Chain
Panel discusses what real-world evidence—and related patient-reporting technology—need to achieve to better influence payer decision-making.
Pharma 2023: Roche Turkey’s Digital Platform for HCPs and Patients
Tool highlights efforts to overcome the challenges of remote disease management in Turkey.